Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Lyka Labs Ltd

About the Company - Lyka Labs Ltd

Lyka Labs Ltd. is a Public Limited Listed company incorporated on 29/12/1976 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1976PLC008738 and registration number is 008738. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 164.35 Cr. and Equity Capital is Rs. 28.69 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Pharmaceuticals4801/B & 4802/A, Ankleshwar Gujarat 393002companysecretary@lykalabs.com.
http://www.lykalabs.com
Management
NamePosition Held
Mr. Babulal JainChairman
Mr. Kunal GandhiManaging Director & CEO
Mr. Yogesh B ShahExecutive Director & CFO
Mr. Sandeep P ParikhIndependent Director
Mrs. Dhara P ShahIndependent Director
Mr. Prashant GodhaNon Executive Director
Mr. Shashil MendosaNon Executive Director

Basic Stock Data of Lyka Labs Ltd

Last Updated: June 15, 2024, 10:01 pm

Market Cap 359 Cr.
Current Price 109
High / Low144/97.9
Stock P/E
Book Value 20.6
Dividend Yield0.00 %
ROCE3.78 %
ROE6.32 %
Face Value 10.0
PEG Ratio0.00

Lyka Labs Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales26.8124.2649.4473.8935.5735.1927.4925.5317.8222.2422.8827.9932.56
Expenses20.8018.0219.5428.2722.5522.5921.1820.5015.6118.9420.2423.8225.69
Operating Profit6.016.2429.9045.6213.0212.606.315.032.213.302.644.176.87
OPM %22.42%25.72%60.48%61.74%36.60%35.81%22.95%19.70%12.40%14.84%11.54%14.90%21.10%
Other Income0.70-0.500.47-3.200.58-2.270.950.98-5.950.020.38-0.180.54
Interest6.596.376.935.574.642.992.913.033.082.851.351.191.28
Depreciation2.122.022.133.522.249.463.593.623.473.473.473.592.84
Profit before tax-2.00-2.6521.3133.336.72-2.120.76-0.64-10.29-3.00-1.80-0.793.29
Tax %7.00%159.25%8.59%16.98%6.55%-607.08%6.58%46.88%-2.24%0.00%-7.22%22.78%38.60%
Net Profit-2.271.1419.5528.436.09-15.070.60-0.38-10.42-3.01-1.85-0.491.78
EPS in Rs-0.790.406.819.912.12-5.250.21-0.13-3.63-0.98-0.56-0.150.54

Last Updated: June 11, 2024, 3:00 am

Lyka Labs Ltd Quarterly Chart

Lyka Labs Ltd Profit & Loss

MonthMar 2012Mar 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales1701271191661301106071618619493106
Expenses155991111391108763736567937689
Operating Profit15288282023-4-2-4201011717
OPM %9%22%7%17%16%21%-6%-3%-6%23%52%18%16%
Other Income1632548-241-300-4-41
Interest301927241519107202620127
Depreciation91291191011788171413
Profit before tax-80-3-34-8-20-15-62-1459-13-2
Tax %0%0%-45%-31%-5%19%5%59%-1%29%35%0%
Net Profit-8-1-5-54-7-19-6-63-1038-13-4
EPS in Rs-3.20-0.33-3.05-2.291.67-2.51-6.14-1.97-21.10-4.0313.59-4.30-1.15
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Lyka Labs Ltd Profit & Loss Yearly Chart

Lyka Labs Ltd Growth

Compounded Sales Growth
10 Years:%
5 Years:9%
3 Years:9%
TTM:19%
Compounded Profit Growth
10 Years:%
5 Years:6%
3 Years:18%
TTM:48%
Stock Price CAGR
10 Years:21%
5 Years:38%
3 Years:27%
1 Year:-12%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:-6%

Last Updated: June 15, 2024, 4:31 pm

Lyka Labs Ltd Balance Sheet

MonthMar 2012Mar 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital22222222222228282929293133
Reserves5144302022162114-43-54-15-335
Preference Capital111110111111
Borrowings133126163136120126112961411631307454
Other Liabilities7797114102788869787453435030
Total Liabilities283289329279242252229216200190186152152
Fixed Assets1379316212210413311610810598946863
CWIP8472227302428312826181617
Investments6600000000000
Other Assets1321431451301079485776866746771
Total Assets283289329279242252229216200190186152152

Lyka Labs Ltd Reserves and Borrowings Chart

Lyka Labs Ltd Cash Flow

MonthMar 2012Mar 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 11189271231112759799
Cash from Investing Activity 125-573717-13-3-4-0-0-67
Cash from Financing Activity -16-13-26-60-30-19-10-233-12-63-22
Net Cash Flow-3364-1-0-3-19-310-5

Lyka Labs Ltd Financial Efficiency Indicators

MonthMar 2013Jun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days21120912412197125754837357989
Inventory Days9991775690139656941566878
Days Payable236363220218266301216192141969198
Cash Conversion Cycle73-64-18-41-79-37-75-76-63-55568
Working Capital Days96-106-88-75-191-456-181-156-7163471
ROCE %10%2%10%7%9%-8%-5%-6%10%61%5%

Lyka Labs Ltd Financial Efficiency Indicators Chart

Lyka Labs Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters19.88%19.88%20.00%20.04%47.79%47.80%47.58%47.58%51.00%54.58%54.81%54.81%
FIIs3.50%3.50%2.07%1.13%1.12%0.76%0.57%0.37%0.18%0.17%0.18%0.17%
DIIs0.47%0.47%1.85%0.47%1.19%3.99%4.00%4.00%3.74%0.41%0.41%0.62%
Public76.15%76.15%76.08%78.36%49.89%47.45%47.85%48.05%45.08%44.84%44.61%44.41%
No. of Shareholders19,35022,12020,67227,72026,22026,96928,43328,51526,82027,20226,65226,422

Lyka Labs Ltd Shareholding Pattern Chart

No. of Lyka Labs Ltd Shareholders

This stock is not held by any mutual fund

Lyka Labs Ltd ROCE Trend

Lyka Labs Ltd EPS Trend

Lyka Labs Ltd Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)-0.79-4.6313.57-4.07-21.29
Diluted EPS (Rs.)-0.79-4.6313.57-4.07-21.29
Cash EPS (Rs.)3.080.3219.45-0.61-19.03
Book Value[Excl.RevalReserv]/Share (Rs.)20.6314.884.70-8.75-5.27
Book Value[Incl.RevalReserv]/Share (Rs.)20.6314.884.70-8.75-5.27
Revenue From Operations / Share (Rs.)33.6030.3367.6530.0621.43
PBDIT / Share (Rs.)5.196.5935.997.41-0.20
PBIT / Share (Rs.)1.321.9929.944.50-2.99
PBT / Share (Rs.)-0.28-4.2920.65-4.93-21.57
Net Profit / Share (Rs.)-0.79-4.2913.40-3.52-21.83
NP After MI And SOA / Share (Rs.)-0.75-4.3013.59-4.03-21.10
PBDIT Margin (%)15.4421.7453.1924.63-0.94
PBIT Margin (%)3.926.5444.2514.98-13.96
PBT Margin (%)-0.83-14.1530.52-16.39-100.63
Net Profit Margin (%)-2.35-14.1319.80-11.69-101.84
NP After MI And SOA Margin (%)-2.23-14.1920.09-13.39-98.45
Return on Networth / Equity (%)-3.65-29.07292.380.000.00
Return on Capital Employeed (%)3.665.1299.579.17-6.41
Return On Assets (%)-1.58-8.7121.01-6.08-30.24
Long Term Debt / Equity (X)0.621.384.63-5.84-8.75
Total Debt / Equity (X)0.841.559.66-6.24-9.75
Asset Turnover Ratio (%)0.720.440.820.300.18
Current Ratio (X)1.351.360.520.590.54
Quick Ratio (X)1.091.140.440.500.43
Inventory Turnover Ratio (X)3.893.054.312.232.12
Interest Coverage Ratio (X)3.511.715.130.81-0.02
Interest Coverage Ratio (Post Tax) (X)0.540.513.230.65-0.46
Enterprise Value (Cr.)402.09381.55501.74229.87166.02
EV / Net Operating Revenue (X)3.624.102.592.672.70
EV / EBITDA (X)23.4218.854.8610.82-286.39
MarketCap / Net Operating Revenue (X)3.153.452.000.860.59
Price / BV (X)5.147.0729.17-2.89-2.55
Price / Net Operating Revenue (X)3.153.452.000.860.59
EarningsYield-0.01-0.040.10-0.15-1.65

Lyka Labs Ltd Profitability Ratios (%)

Lyka Labs Ltd Liquidity Ratios

Lyka Labs Ltd Liquidity Ratios (%)

Lyka Labs Ltd Interest Coverage Ratios (%)

Lyka Labs Ltd Valuation Ratios

Fair Value

Fair Value: 19.92

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Overvalued: 81.73% compared to the current price 109

Default values used*: Deafault value of 15 for Stock P/E is used

Intrinsic Value: 36.60

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Overvalued: 66.42% compared to the current price ₹109

Default values used*: Deafault value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: 83.75%

*Investments are subject to market risks

Strength and Weakness of Lyka Labs Ltd Stock

StrengthWeakness
  1. The stock has a low average Working Capital Days of -93.08, which is a positive sign.
  2. The stock has a low average Cash Conversion Cycle of -21.83, which is a positive sign.
  3. The company has higher reserves (10.62 cr) compared to borrowings (0.85 cr), indicating strong financial stability.
  1. The stock has a low average ROCE of 7.92%, which may not be favorable.
  2. The company has not shown consistent growth in sales (114.85) and profit (-6.54).

FAQ

What is the latest fair value of Lyka Labs Ltd?

The latest fair value of Lyka Labs Ltd is ₹19.92.

What is the Market Cap of Lyka Labs Ltd?

The Market Cap of Lyka Labs Ltd is 359 Cr..

What is the current Stock Price of Lyka Labs Ltd as on 21 June 2024?

The current stock price of Lyka Labs Ltd as on 21 June 2024 is ₹109.

What is the High / Low of Lyka Labs Ltd stocks in FY 2024?

In FY 2024, the High / Low of Lyka Labs Ltd stocks is 144/97.9.

What is the Stock P/E of Lyka Labs Ltd?

The Stock P/E of Lyka Labs Ltd is .

What is the Book Value of Lyka Labs Ltd?

The Book Value of Lyka Labs Ltd is 20.6.

What is the Dividend Yield of Lyka Labs Ltd?

The Dividend Yield of Lyka Labs Ltd is 0.00 %.

What is the ROCE of Lyka Labs Ltd?

The ROCE of Lyka Labs Ltd is 3.78 %.

What is the ROE of Lyka Labs Ltd?

The ROE of Lyka Labs Ltd is 6.32 %.

What is the Face Value of Lyka Labs Ltd?

The Face Value of Lyka Labs Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Lyka Labs Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE